Japanese Team To Try Stem Cells To Fix Premature Infant Disease
This article was originally published in PharmAsia News
Executive Summary
A biomedical engineering team in Japan plans to test transplanting stem cells in newborns to regenerate lost nerve cells behind a type of encephalopathy. The brain disease PVL occurs in about 10 percent of infants delivered by 33 weeks of pregnancy. The Nagoya City University team plans to experiment on animals by using pluropotent stem cells from mice and monkeys to generate neural stem cells that would be transplanted back into the days-old animal engineered to develop PVL symptoms. (Click here for more
|
A biomedical engineering team in Japan plans to test transplanting stem cells in newborns to regenerate lost nerve cells behind a type of encephalopathy. The brain disease PVL occurs in about 10 percent of infants delivered by 33 weeks of pregnancy. The Nagoya City University team plans to experiment on animals by using pluropotent stem cells from mice and monkeys to generate neural stem cells that would be transplanted back into the days-old animal engineered to develop PVL symptoms. (Click here for more) "Medical Team Eyes Using iPS Cells To Treat Brain Disease In Infants" - Japan Today (6/1/08) |